vs
安朗杰（ALLE）与Evolent Health, Inc.（EVH）财务数据对比。点击上方公司名可切换其他公司
安朗杰的季度营收约是Evolent Health, Inc.的2.2倍（$1.0B vs $468.7M）。安朗杰净利率更高（14.3% vs -91.6%，领先105.8%）。安朗杰同比增速更快（9.3% vs -27.5%）。过去两年安朗杰的营收复合增速更高（7.5% vs -14.4%）
安朗杰是全球知名的安防产品及解决方案供应商，面向全球生产销售机械与电子类安防产品，包括闭门器、出入口控制设备、锁具、电子门禁系统、考勤与人员效能管理系统、门体系统及相关配件，服务商业、公共机构、住宅等多领域终端用户
马奎尔健康是一家美国营利性医疗管理企业，目前为森特里奇旗下子公司，核心服务对象为特殊群体，业务聚焦医疗领域多个细分赛道。客户群体涵盖健康保险计划、其他管理式医疗机构、企业、工会、各类军事与政府机构以及第三方管理机构，2021年位列财富美国500强第390名。
ALLE vs EVH — 直观对比
营收规模更大
ALLE
是对方的2.2倍
$468.7M
营收增速更快
ALLE
高出36.8%
-27.5%
净利率更高
ALLE
高出105.8%
-91.6%
两年增速更快
ALLE
近两年复合增速
-14.4%
损益表 — Q4 2025 vs Q4 2025
| 指标 | | |
|---|---|---|
| 营收 | $1.0B | $468.7M |
| 净利润 | $147.5M | $-429.1M |
| 毛利率 | 44.5% | 20.7% |
| 营业利润率 | 20.3% | -87.1% |
| 净利率 | 14.3% | -91.6% |
| 营收同比 | 9.3% | -27.5% |
| 净利润同比 | 2.4% | -1782.0% |
| 每股收益（稀释后） | $1.70 | $-3.76 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收ALLEEVH
| Q4 25 | $1.0B | $468.7M | ||
| Q3 25 | $1.1B | $479.5M | ||
| Q2 25 | $1.0B | $444.3M | ||
| Q1 25 | $941.9M | $483.6M | ||
| Q4 24 | $945.6M | $646.5M | ||
| Q3 24 | $967.1M | $621.4M | ||
| Q2 24 | $965.6M | $647.1M | ||
| Q1 24 | $893.9M | $639.7M |
净利润ALLEEVH
| Q4 25 | $147.5M | $-429.1M | ||
| Q3 25 | $188.4M | $-20.9M | ||
| Q2 25 | $159.7M | $-19.9M | ||
| Q1 25 | $148.2M | $-64.6M | ||
| Q4 24 | $144.1M | $-22.8M | ||
| Q3 24 | $174.2M | $-23.1M | ||
| Q2 24 | $155.4M | $1.6M | ||
| Q1 24 | $123.8M | $-17.3M |
毛利率ALLEEVH
| Q4 25 | 44.5% | 20.7% | ||
| Q3 25 | 45.8% | 20.8% | ||
| Q2 25 | 45.6% | 22.6% | ||
| Q1 25 | 44.9% | 21.2% | ||
| Q4 24 | 44.1% | 11.7% | ||
| Q3 24 | 44.7% | 13.0% | ||
| Q2 24 | 44.4% | 16.5% | ||
| Q1 24 | 43.8% | 16.3% |
营业利润率ALLEEVH
| Q4 25 | 20.3% | -87.1% | ||
| Q3 25 | 21.8% | 0.2% | ||
| Q2 25 | 21.5% | -0.3% | ||
| Q1 25 | 20.9% | -0.3% | ||
| Q4 24 | 19.5% | -2.9% | ||
| Q3 24 | 22.2% | -2.6% | ||
| Q2 24 | 21.6% | 1.2% | ||
| Q1 24 | 19.3% | -2.1% |
净利率ALLEEVH
| Q4 25 | 14.3% | -91.6% | ||
| Q3 25 | 17.6% | -4.4% | ||
| Q2 25 | 15.6% | -4.5% | ||
| Q1 25 | 15.7% | -13.4% | ||
| Q4 24 | 15.2% | -3.5% | ||
| Q3 24 | 18.0% | -3.7% | ||
| Q2 24 | 16.1% | 0.2% | ||
| Q1 24 | 13.8% | -2.7% |
每股收益（稀释后）ALLEEVH
| Q4 25 | $1.70 | $-3.76 | ||
| Q3 25 | $2.18 | $-0.24 | ||
| Q2 25 | $1.85 | $-0.44 | ||
| Q1 25 | $1.71 | $-0.63 | ||
| Q4 24 | $1.65 | $-0.26 | ||
| Q3 24 | $1.99 | $-0.27 | ||
| Q2 24 | $1.77 | $-0.06 | ||
| Q1 24 | $1.41 | $-0.22 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $356.2M | $151.9M |
| 总债务越低越好 | $2.0B | — |
| 股东权益账面价值 | $2.1B | $415.2M |
| 总资产 | $5.2B | $1.9B |
| 负债/权益比越低杠杆越低 | 0.96× | — |
8季度趋势，按日历期对齐
现金及短期投资ALLEEVH
| Q4 25 | $356.2M | $151.9M | ||
| Q3 25 | $302.7M | $116.7M | ||
| Q2 25 | $656.8M | $151.0M | ||
| Q1 25 | $494.5M | $246.5M | ||
| Q4 24 | $503.8M | $104.2M | ||
| Q3 24 | $878.9M | $96.6M | ||
| Q2 24 | $747.5M | $101.3M | ||
| Q1 24 | $391.8M | $165.1M |
总债务ALLEEVH
| Q4 25 | $2.0B | — | ||
| Q3 25 | $2.1B | — | ||
| Q2 25 | $2.1B | — | ||
| Q1 25 | $2.0B | — | ||
| Q4 24 | $2.0B | — | ||
| Q3 24 | $2.4B | — | ||
| Q2 24 | $2.4B | — | ||
| Q1 24 | $2.0B | — |
股东权益ALLEEVH
| Q4 25 | $2.1B | $415.2M | ||
| Q3 25 | $1.9B | $842.2M | ||
| Q2 25 | $1.8B | $896.0M | ||
| Q1 25 | $1.6B | $935.5M | ||
| Q4 24 | $1.5B | $1.0B | ||
| Q3 24 | $1.6B | $1.0B | ||
| Q2 24 | $1.4B | $1.1B | ||
| Q1 24 | $1.4B | $1.0B |
总资产ALLEEVH
| Q4 25 | $5.2B | $1.9B | ||
| Q3 25 | $5.2B | $2.5B | ||
| Q2 25 | $4.9B | $2.5B | ||
| Q1 25 | $4.6B | $2.7B | ||
| Q4 24 | $4.5B | $2.5B | ||
| Q3 24 | $5.0B | $2.5B | ||
| Q2 24 | $4.8B | $2.5B | ||
| Q1 24 | $4.3B | $2.6B |
负债/权益比ALLEEVH
| Q4 25 | 0.96× | — | ||
| Q3 25 | 1.07× | — | ||
| Q2 25 | 1.16× | — | ||
| Q1 25 | 1.24× | — | ||
| Q4 24 | 1.33× | — | ||
| Q3 24 | 1.53× | — | ||
| Q2 24 | 1.69× | — | ||
| Q1 24 | 1.49× | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $240.1M | $48.8M |
| 自由现金流经营现金流 - 资本支出 | $200.5M | — |
| 自由现金流率自由现金流/营收 | 19.4% | — |
| 资本支出强度资本支出/营收 | 3.8% | — |
| 现金转化率经营现金流/净利润 | 1.63× | — |
| 过去12个月自由现金流最近4个季度 | $685.7M | — |
8季度趋势，按日历期对齐
经营现金流ALLEEVH
| Q4 25 | $240.1M | $48.8M | ||
| Q3 25 | $229.5M | $15.8M | ||
| Q2 25 | $209.7M | $-30.3M | ||
| Q1 25 | $104.5M | $4.6M | ||
| Q4 24 | $219.0M | $-26.2M | ||
| Q3 24 | $231.9M | $18.7M | ||
| Q2 24 | $173.0M | $21.4M | ||
| Q1 24 | $51.1M | $4.9M |
自由现金流ALLEEVH
| Q4 25 | $200.5M | — | ||
| Q3 25 | $209.8M | — | ||
| Q2 25 | $192.0M | — | ||
| Q1 25 | $83.4M | — | ||
| Q4 24 | $194.9M | — | ||
| Q3 24 | $212.0M | — | ||
| Q2 24 | $152.1M | — | ||
| Q1 24 | $23.9M | — |
自由现金流率ALLEEVH
| Q4 25 | 19.4% | — | ||
| Q3 25 | 19.6% | — | ||
| Q2 25 | 18.8% | — | ||
| Q1 25 | 8.9% | — | ||
| Q4 24 | 20.6% | — | ||
| Q3 24 | 21.9% | — | ||
| Q2 24 | 15.8% | — | ||
| Q1 24 | 2.7% | — |
资本支出强度ALLEEVH
| Q4 25 | 3.8% | — | ||
| Q3 25 | 1.8% | — | ||
| Q2 25 | 1.7% | — | ||
| Q1 25 | 2.2% | — | ||
| Q4 24 | 2.5% | — | ||
| Q3 24 | 2.1% | — | ||
| Q2 24 | 2.2% | — | ||
| Q1 24 | 3.0% | — |
现金转化率ALLEEVH
| Q4 25 | 1.63× | — | ||
| Q3 25 | 1.22× | — | ||
| Q2 25 | 1.31× | — | ||
| Q1 25 | 0.71× | — | ||
| Q4 24 | 1.52× | — | ||
| Q3 24 | 1.33× | — | ||
| Q2 24 | 1.11× | 13.42× | ||
| Q1 24 | 0.41× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
ALLE
| Products | $750.2M | 73% |
| Allegion International | $237.7M | 23% |
| Services | $45.2M | 4% |
EVH
| Commercial And Other Customers | $147.9M | 32% |
| Medicare Customers | $111.2M | 24% |
| Specialty Technology And Services Suite | $95.7M | 20% |
| Administrative Service | $55.8M | 12% |
| Cases | $47.7M | 10% |
| Related Party | $4.5M | 1% |
